ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Influence of CAG Repeat Polymorphism on the Targets of Testosterone Action
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 109766" data-attributes="member: 13851"><p><em>It should be finally acknowledged that the AR CAG repeat polymorphism plays a role in testosterone replacement therapy of males with hypogonadotropic gonadism since shorter AR gene CAG tract lengths was found to yield greater metabolic improvement in response to testosterone administration.</em></p><p></p><p></p><p></p><p></p><p><strong>Conclusion</strong></p><p><strong></strong></p><p><strong><em>*in 2015 a large body of evidence indicated an important role for AR CAG polymorphism in conditioning the peripheral effect of testosterone even if its <u>contribution warrants further assessment because of the many controversial findings in each androgen-related action</u></em></strong></p><p><strong><em></em></strong></p><p><strong><em>*at <u>present AR CAG polymorphism is not recommended</u> in the routine setting however in the near future it could become of clinical relevance because of the theoretical possibility of identifying subjects more or less at risk for various disorders more or less responsive to testosterone treatment</em></strong></p><p><strong><em></em></strong></p><p><em><strong>*study of CAG repeat length could <u>allow us to individually tailor testosterone replacement therapy</u> as subjects with shorter CAG repeat could need lower doses of testosterone while men with longer repeats could require higher ones</strong></em></p></blockquote><p></p>
[QUOTE="madman, post: 109766, member: 13851"] [I]It should be finally acknowledged that the AR CAG repeat polymorphism plays a role in testosterone replacement therapy of males with hypogonadotropic gonadism since shorter AR gene CAG tract lengths was found to yield greater metabolic improvement in response to testosterone administration.[/I] [B]Conclusion [I]*in 2015 a large body of evidence indicated an important role for AR CAG polymorphism in conditioning the peripheral effect of testosterone even if its [U]contribution warrants further assessment because of the many controversial findings in each androgen-related action[/U] *at [U]present AR CAG polymorphism is not recommended[/U] in the routine setting however in the near future it could become of clinical relevance because of the theoretical possibility of identifying subjects more or less at risk for various disorders more or less responsive to testosterone treatment [/I][/B] [I][B]*study of CAG repeat length could [U]allow us to individually tailor testosterone replacement therapy[/U] as subjects with shorter CAG repeat could need lower doses of testosterone while men with longer repeats could require higher ones[/B][/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Influence of CAG Repeat Polymorphism on the Targets of Testosterone Action
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top